I made the case a while ago about P and B-OM not having to do a PIII trial. At minimum why a Control arm for B-OM? We know statistically where OM patients stand. A lot of data to support it. Been putting up many large bids AON none take. Next week may start with a 50,000 share bid with just a limit cap. Maybe Monday we here something too. If not I’m adding.
